Mucopolysaccharidosis Type VI

The yearly cost of using galsulfase enzyme replacement therapy (ERT) for each person with Mucopolysaccharidosis Type VI in the United States is about $441,000 as of July 16th, 2013. This is the estimated cost if a person did not have insurance, but depending on the health insurance plan that a person with Mucopolysaccharidosis Type VI has, the cost may be much less.